PepGen (PEPG) Cash & Equivalents (2021 - 2026)
PepGen (PEPG) reported Cash & Equivalents of $22.76 million for Q2 2026, down 35.1% from $35.07 million a year earlier and down 46.0% from the prior quarter.
Powered by 
Analysis
PepGen (PEPG) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, PepGen posted Cash & Equivalents of $60.51 million, up 22.4% from FY2024.
- Cash & Equivalents has a four-year compound annual growth rate of -17.9% (FY2021 to FY2025).
- By year, Cash & Equivalents came in at $49.42 million in FY2024 (-38.8%), $80.77 million in FY2023 (-55.6%), $181.75 million in FY2022 (+36.8%) and $132.9 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q2 2021.
- Year over year, Cash & Equivalents gained in two of the last eight quarters, with growth averaging 0.1%.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2025 (growth of 237.6%); the low point was Q1 2025 (a decline of 67.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $42.15 million (Q1 2026), $60.51 million (Q4 2025) and $142.78 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | PepGen | 167.61 Mn | 167.61 Mn | - | 22.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.76 Mn |
| Mar 31, 2026 | 42.15 Mn |
| Dec 31, 2025 | 60.51 Mn |
| Sep 30, 2025 | 142.78 Mn |
| Jun 30, 2025 | 35.07 Mn |
| Mar 31, 2025 | 43.63 Mn |
| Dec 31, 2024 | 49.42 Mn |
| Sep 30, 2024 | 42.29 Mn |
| Jun 30, 2024 | 66.09 Mn |
| Mar 31, 2024 | 133.85 Mn |
| Dec 31, 2023 | 80.77 Mn |
| Sep 30, 2023 | 129.54 Mn |
| Jun 30, 2023 | 147.03 Mn |
| Mar 31, 2023 | 165.40 Mn |
| Dec 31, 2022 | 181.75 Mn |
| Sep 30, 2022 | 195.78 Mn |
| Jun 30, 2022 | 218.82 Mn |
| Mar 31, 2022 | 118.85 Mn |
| Dec 31, 2021 | 132.90 Mn |
| Sep 30, 2021 | 141.54 Mn |
API Access
PepGen Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PEPG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PEPG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PEPG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();